Galderma Group revenue and financials
In the fiscal year ended December 2025, Galderma Group reported revenue of $5.24B (+18.04% year over year). Net income was $613M, a net margin of 11.7%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +18.04%
- 2025 vs 2024
- Net income growth
- +165.37%
- 2025 vs 2024
- Net margin
- 11.7%
- 2024: 5.2%
How Galderma Group is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 11.1% a year on average over the last 3 years
Compound annual growth rate: from $3.82B in 2022 to $5.24B in 2025.
Revenue has grown for 4 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 10.5% to 16.9%
Operating income over revenue, 2022 → 2025: 6.4 percentage points.
Profits turn into cash: free cash flow equal to 188% of net income
Totals for fiscal years 2023–2025: free cash flow $1.48B, net income $787M.
Shares outstanding down 95.4% in 3 years
Average diluted shares, 2022 → 2025: with fewer shares, each one represents a larger stake in the company.
Profitable in 2 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 5,241 | 4,440 | 4,117 | 3,824 | 3,445 |
| Cost of revenue | 1,632 | 1,355 | 1,232 | 1,194 | 1,034 |
| Gross profit | 3,609 | 3,085 | 2,885 | 2,630 | 2,411 |
| Selling, general and administrative | 2,490 | 2,151 | 1,990 | 1,908 | 1,711 |
| Research and development | 245 | 260 | 287 | 316 | 343 |
| Operating income | 885 | 671 | 606 | 401 | 350 |
| EBIT | 885 | 671 | 606 | 401 | 350 |
| EBITDA | 1,134 | 891 | 818 | 630 | 567 |
| Interest expense | 173 | 352 | 561 | 398 | 353 |
| Pre-tax income | 639 | 310 | 11.0 | -51.9 | -79.6 |
| Income tax | 26.0 | 79.0 | 68.0 | 45.0 | 4.6 |
| Net income | 613 | 231 | -57.0 | -98.5 | -154 |
| Net income to common shareholders | 613 | 231 | -57.0 | -98.5 | -154 |
| Basic EPS | 2.60 | 0.97 | -0.24 | -0.02 | -0.03 |
| Diluted EPS | 2.58 | 0.97 | -0.24 | -0.02 | -0.03 |
| Average shares (basic) | 236 | 238 | 238 | 5,188 | 5,188 |
| Average shares (diluted) | 237 | 238 | 238 | 5,188 | 5,188 |
| Dividend per share | 0.44 | 0.17 | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|
| Total revenue | 3,148 | 2,775 | 2,466 | 2,224 | 2,216 | 2,102 | 2,015 |
| Cost of revenue | 938 | 876 | 756 | 688 | 667 | 648 | 584 |
| Gross profit | 2,210 | 1,899 | 1,710 | 1,536 | 1,549 | 1,454 | 1,431 |
| Selling, general and administrative | 1,435 | 1,281 | 1,209 | 1,051 | 1,100 | 992 | 998 |
| Research and development | 137 | 141 | 104 | 125 | 135 | 150 | 137 |
| Operating income | 637 | 494 | 391 | 356 | 315 | 310 | 296 |
| EBIT | 637 | 494 | 391 | 356 | 315 | 310 | 296 |
| EBITDA | 801 | 603 | 549 | 457 | 434 | 419 | 399 |
| Interest expense | 77.0 | 77.0 | 96.0 | 118 | 234 | 264 | 297 |
| Pre-tax income | 554 | 387 | 252 | 233 | 77.0 | 28.0 | -17.0 |
| Income tax | 110 | -32.0 | 58.0 | 49.0 | 30.0 | 89.0 | -21.0 |
| Net income | 444 | 419 | 194 | 184 | 47.0 | -61.0 | 4.0 |
| Net income to common shareholders | 444 | 419 | 194 | 184 | 47.0 | -61.0 | 4.0 |
| Basic EPS | 1.90 | 1.79 | 0.82 | 0.77 | 0.20 | -0.26 | 0.02 |
| Diluted EPS | 1.89 | 1.76 | 0.82 | 0.77 | 0.20 | -0.26 | 0.02 |
| Average shares (basic) | 234 | 235 | 237 | 237 | 238 | 238 | 238 |
| Average shares (diluted) | 235 | 236 | 238 | 238 | 238 | 238 | 238 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 13,393 | 12,617 | 12,471 | 12,415 | 12,572 |
| Current assets | 2,437 | 1,843 | 1,616 | 1,507 | 1,517 |
| Cash and equivalents | 780 | 457 | 368 | 234 | 287 |
| Receivables | 1,062 | 905 | 765 | 791 | 732 |
| Inventory | 525 | 403 | 420 | 442 | 347 |
| Net property, plant and equipment | 744 | 577 | 529 | 401 | 342 |
| Goodwill | 5,129 | 5,129 | 5,129 | 5,129 | 5,141 |
| Other intangible assets | 4,639 | 4,829 | 4,923 | 5,100 | 5,282 |
| Long-term investments | 3.0 | 1.0 | 10.0 | 8.8 | 7.3 |
| Current liabilities | 2,055 | 1,528 | 1,571 | 1,961 | 1,857 |
| Accounts payable | 799 | 571 | 557 | 602 | 502 |
| Long-term debt | 2,579 | 2,636 | 4,748 | 5,164 | 5,199 |
| Total debt | 2,753 | 2,756 | 4,905 | 5,297 | 5,312 |
| Total liabilities | 5,244 | 4,827 | 7,102 | 7,946 | 8,024 |
| Total equity (incl. minority) | 8,149 | 7,790 | 5,369 | 4,469 | 4,548 |
| Retained earnings | 6,347 | 5,676 | -901 | -844 | -745 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|
| Total assets | 13,526 | 13,393 | 12,877 | 12,617 | 12,579 | 12,471 | — |
| Current assets | 2,649 | 2,437 | 1,910 | 1,843 | 1,793 | 1,616 | — |
| Cash and equivalents | 839 | 780 | 458 | 457 | 385 | 368 | — |
| Receivables | 1,088 | 1,062 | 865 | 905 | 928 | 765 | — |
| Inventory | 650 | 525 | 502 | 403 | 414 | 420 | — |
| Net property, plant and equipment | 789 | 744 | 672 | 577 | 550 | 529 | — |
| Goodwill | 5,129 | 5,129 | 5,129 | 5,129 | 5,129 | 5,129 | — |
| Other intangible assets | 4,521 | 4,639 | 4,751 | 4,829 | 4,867 | 4,923 | — |
| Long-term investments | 1.0 | 3.0 | 3.0 | 1.0 | 3.0 | 10.0 | — |
| Current liabilities | 2,133 | 2,055 | 1,750 | 1,528 | 1,498 | 1,571 | — |
| Accounts payable | 820 | 799 | 631 | 571 | 550 | 557 | — |
| Long-term debt | 2,503 | 2,579 | 2,700 | 2,636 | 2,822 | 4,748 | — |
| Total debt | 2,715 | 2,753 | 2,845 | 2,756 | 2,943 | 4,905 | — |
| Total liabilities | 5,311 | 5,244 | 5,147 | 4,827 | 4,947 | 7,102 | — |
| Total equity (incl. minority) | 8,215 | 8,149 | 7,730 | 7,790 | 7,632 | 5,369 | — |
| Retained earnings | 6,798 | 6,347 | 5,901 | 5,676 | 5,469 | -901 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 1,185 | 488 | 165 | 111 | 196 |
| Depreciation and amortization | 286 | 249 | 236 | 251 | 239 |
| Capital expenditure | -113 | -128 | -121 | -102 | -49.9 |
| Investing cash flow | -154 | -326 | -174 | -66.5 | -523 |
| Financing cash flow | -728 | -58.0 | 142 | -79.4 | 307 |
| Dividends paid | -41.0 | — | — | — | — |
| Share repurchases | -363 | -15.0 | 0.0 | — | — |
| Debt issued | 1,408 | 3,601 | 856 | 400 | 396 |
| Debt repaid | -1,701 | -5,777 | -1,725 | -472 | -78.8 |
| Effect of exchange rates | 20.0 | -14.0 | 0.0 | -24.9 | -16.5 |
| Net change in cash | 323 | 89.0 | 134 | -59.5 | -37.1 |
| Free cash flow | 1,072 | 360 | 44.0 | 9.7 | 146 |
| Levered free cash flow | 905 | 131 | 136 | 196 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 572 | 634 | 551 | 400 | 88.0 | 331 | -166 |
| Depreciation and amortization | 164 | 146 | 158 | 130 | 119 | 122 | 114 |
| Capital expenditure | -56.0 | -70.0 | -43.0 | -64.0 | -64.0 | -92.0 | -29.0 |
| Investing cash flow | -64.0 | -81.0 | -73.0 | -146 | -180 | -71.0 | -103 |
| Financing cash flow | -454 | -233 | -495 | -181 | 123 | -146 | 288 |
| Dividends paid | -104 | 0.0 | -41.0 | — | — | — | — |
| Share repurchases | -302 | -40.0 | -323 | -15.0 | — | — | — |
| Debt issued | 607 | 243 | 1,165 | 633 | 2,968 | 159 | 697 |
| Debt repaid | -651 | -414 | -1,287 | -802 | -4,975 | -578 | -1,147 |
| Effect of exchange rates | 4.0 | 2.0 | 18.0 | 0.0 | -14.0 | 8.0 | -8.0 |
| Net change in cash | 59.0 | 322 | 1.0 | 72.0 | 17.0 | 123 | 11.0 |
| Free cash flow | 516 | 564 | 508 | 336 | 24.0 | 239 | -195 |
| Levered free cash flow | 410 | 465 | 440 | 225 | -93.4 | 136 | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
